IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Albemarle completes sale of antioxidant business to SI Group

6:31 AM MDT | September 2, 2014 | Francinia Protti-Alvarez

Albemarle has completed the previously announced sale of its antioxidant, ibuprofen, and propofol businesses and related assets to SI Group (Schenectady, NY), Albemarle said today. Financial terms of the transaction have not been disclosed. The transaction includes manufacturing sites at Orangeburg, SC; and Jinshan, China. The deal includes patented technology and patents for the Ethanox, ALBlend, and Ethapos antioxidant product lines. Certain applications and technical support capabilities located at Baton Rouge and Shanghai were also included in the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa